INTRODUCTIONHypertension is one of the most important public health problems worldwide and if left untreated, 50% die of CAD, 33% die of stroke and 10-15% die of renal failure. 1 These vascular complications of the Hypertension are mainly due to the damage to vascular endothelium (endothelial dysfunction) caused by shear stress of Hypertension which is the initial event in atherosclerotic process. Hence the present study is aimed at observing the association of the essential hypertension with endothelial dysfunction and left ventricular dysfunction which are assessed noninvasively and to evaluate the effects of statins (non-lipid effects) on endothelial and left ventricular dysfunction besides their conventional effect on lipid profile.
METHODSHypertensive is diagnosed when SBP is ≥140 mm Hg and or DBP is ≥90mm Hg as per JNC-VII criteria, 2003. 2 Patients with Secondary hypertension, Diabetes mellitus, Hyperlipidemia, Ischemic heart disease and history of smoking were excluded from the study.
ABSTRACTBackground: Hypertension is one of the commonest diseases affecting the mankind which is associated with endothelial dysfunction and left ventricular dysfunction and hence the study is aimed to observe the effects of statins on endothelial and left ventricular dysfunction. Methods: 15 hypertensive patients were given atorvastatin for 4 weeks and compared with sex and aged matched 15 controls after a detailed Clinical history, clinical examination, biochemical investigations, chest X-ray, electrocardiogram, echocardiogram and Doppler study of brachial artery. Results: Both study group and control group consisted of 10 males and 5 females who have dyslipidemia, endothelial and ventricular dysfunction. After a 4 weeks of study, in study group, flow mediated brachial artery diameter (FMD%) increased significantly (11.39%, P<0.01) from 7.37% to 18.76%, mean LV systolic function (EF) improved significantly (10.73%, P:<0.01) from 54.6% to 60.65%, LV diastolic function was normalized in 7 (46.67%) and improved in 5 (33.33%) patients, the mean systolic and diastolic BP decreased significantly (12.03%, P<0.01, 10.29%, P<0.01) from 149.66mmHg to 131.66mmHg and from 90.66mmHg to 81.33mmHg respectively, while in control group FMD increased marginally (1.07%) from 7.50% to 8.57%, LV EF marginally improved (1.47%) to 54.86% from 54.06%; no improvement in diastolic dysfunction, mean systolic and diastolic BP decreased marginally (6.25%, 0.74%) from 149.33 mmHg to 140mmHg and from 90.33mmHg to 89.66mmHg respectively. Conclusions: Statins improve not only lipid profile but also endothelial and LV functions which resulted in significant reduction of systolic and diastolic BP. Hence it is reasonable to treat all hypertensive patients with statins besides concurrent hypertension treatment.